Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

China flag China · Delayed Price · Currency is CNY
3.200
+0.040 (1.27%)
Jul 3, 2026, 3:00 PM CST
Market Cap2.51B -18.8%
Revenue (ttm)1.72B -18.2%
Net Income-349.70M
EPS-0.45
Shares Out 784.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,918,264
Open3.190
Previous Close3.160
Day's Range3.100 - 3.270
52-Week Range2.850 - 5.270
Beta0.21
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:600594

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, gynecological, tonic, oncology, orthopedics, gastroenterology, andrology an... [Read more]

Sector Healthcare
Founded 1995
Employees 4,832
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600594
Full Company Profile

Financial Performance

In 2025, SHA:600594's revenue was 1.86 billion, a decrease of -14.31% compared to the previous year's 2.17 billion. Losses were -329.56 million, 3.89% more than in 2024.

Financial Statements